Figure 1.
The proportions of patients with A) American College of Rheumatology 20% improvement criteria (ACR20) response or B) ACR50 response through week 256. MTX = methotrexate.
The proportions of patients with A) American College of Rheumatology 20% improvement criteria (ACR20) response or B) ACR50 response through week 256. MTX = methotrexate.